FDA Head Proposes Charging Compounding Pharmacies For Oversight
Since the NECC case came to light, the FDA has insisted that its authority over specialty pharmacies is too limited. Hamburg
fda head proposes charging compounding pharmacies oversight necc case come light fda insist authority specialty pharmacy limited hamburg